Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
(NASDAQ: PHVS) Delayed: 32.19 -0.8 (2.42%)
Previous Close $32.99    52 Week High $ 
Open $33.08    52 Week Low $ 
Day High $33.62    P/E N/A 
Day Low $32.04    EPS $ 
Volume 283,890